Alexandrina Vodenitcharova

Alexandrina Vodenitcharova

Auto-generated profile, based on publicly available information

Alexandrina Vodenitcharova

Medical University of Sofia, Sofia, Bulgaria

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
EPElisaveta Petrova-Geretto
Elisaveta Petrova-Geretto
AVAlexandrina Vodenitcharova
Alexandrina Vodenitcharova
Guenka PetrovaGuenka Petrova
Guenka Petrova
Background/Objectives: This article emphasizes the comprehensive importance of vaccination, exploring its role in disease prevention, addressing growing concerns around vaccine hesitancy, and underscoring the crucial need for high vaccination coverage rates. Methods: Our review examines EU-level and national policies on vaccination, utilizing EU sources, with a specific focus on regulatory and policy documents. Vaccination calendars in the EU were reviewed through the ECDC Vaccine Scheduler webpage. The parameters of this literature review were further selected in collaboration with an Emory Health sciences librarian using the following search terms: healthcare providers, communication, public health, informed consent, and bioethics. Results: The analysis of limited articles on community engagement, moral and political philosophy, and public health ethics informs the ethical consideration of informed consent in public health interventions. Countries exhibit varying relationships between their vaccination programs and society, with technocratic and populist influences shaping vaccination policies. Conclusions: Europe demonstrates diversity in vaccination policies, with availability, funding, and scheduling reflecting distinct approaches to vaccination.

6 February 2018 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
AYAntoniya Yordanova Yanakieva
Antoniya Yordanova Yanakieva
AVAlexandrina Vodenitcharova
Alexandrina Vodenitcharova
KPKristina Popova
Kristina Popova
MDMariela Deliverska
Mariela Deliverska

1 March 2026 in Acta Medica Bulgarica
Verified
Journal Article
Open access
PDF file
BBB. Bayram
B. Bayram
NLN. Leventi
N. Leventi
AVA. Vodenicharova
A. Vodenicharova
ALA. Lamprianidou
A. Lamprianidou
MCM. Costantini
M. Costantini
Artificial intelligence (AI) is reshaping healthcare by enhancing diagnostic precision, treatment personalization, and overall patient care. By leveraging technologies such as machine learning, deep learning, natural language processing, and computer vision, AI enables faster and more accurate decision-making, supports drug discovery and development, and facilitates remote patient monitoring. Beyond improving clinical outcomes, AI also contributes to holistic well-being by addressing physical, mental, social, occupational, and environmental health. Wearable AI devices promote proactive health management, virtual assistants improve mental health accessibility, and predictive analytics enable early intervention for disease prevention. However, the integration of AI in healthcare presents challenges, including data privacy concerns, algorithmic bias, and the need for transparency and trust. Ensuring the responsible and equitable deployment of AI requires robust ethical guidelines, interdisciplinary collaboration, and policies that safeguard patient rights while maximizing the technology’s benefits. By exploring both the transformative potential and inherent challenges of AI, this paper aims to highlight the critical role of AI in shaping the future of healthcare and human well-being.

1 May 2020 in Acta Medica Bulgarica
Verified
Journal Article
Open access
PDF file
BVB. Vasileva
B. Vasileva
ANAnd
And
AVAl. Vodenicharova
Al. Vodenicharova
A vital aspect of the medical activity on which the medical care quality directly depends has been the doctor-patient relationship; it is of complex nature and is formed by a number of factors: professional ethics, communication culture of the doctor, the patients’ confidence in the doctor, etc. From an ethical point of view, the confidence of the patient has been an ethical indicator and criterion of particular importance for the quality and interpersonal relationship between the doctor and the patient. Data from the overview of a number of papers, as well as data from our own empirical study, has indicated the presence of a number of unresolved problems in this relationship. That has raised the significant necessity of a more thorough and comprehensive training of the medical staffin professional medical ethics in undergraduate and postgraduate training.

27 November 2025 in Pharmacia
Verified
Journal Article
Open access
PDF file
SGSvetlin Georgiev Georgiev
Svetlin Georgiev Georgiev
Borislav BorissovBorislav Borissov
Borislav Borissov
AVAlexandrina Vodenicharova
Alexandrina Vodenicharova
AYAntoniya Yordanova Yanakieva
Antoniya Yordanova Yanakieva
Bulgaria is assumed to be the country with the lowest COVID-19 vaccination coverage in the EU. The present study aims to highlight the economic impact of vaccine hesitancy. The period analyzed is from 1 January 2021 to 31 December 2021, examining hospitalization costs for COVID-19 patients, vaccine application costs, and vaccine type and dose administered. Results demonstrate a net impact of BGN 97 686 089 (€49 946 104) if 30% of the eligible population had been vaccinated and BGN 146 529 133 (€74 919 156) if a 45% rate had been achieved. In addition, 5.1 million unused doses were scrapped—more than those administered. The public health impact of vaccine hesitancy in Bulgaria led to a preventable medical crisis, substantial economic losses due to avoidable hospitalizations, and significant additional costs associated with the destruction of unused vaccines.

27 February 2026 in Pharmacia
Verified
Journal Article
Open access
PDF file
MVMaya Vizeva
Maya Vizeva
AVAlexandrina Vodenicharova
Alexandrina Vodenicharova
SVStoyan Vizev
Stoyan Vizev
TDTsvetomir Dimitrov
Tsvetomir Dimitrov
TDTanya Dimitrova
Tanya Dimitrova
Chronic pharmacotherapy poses significant challenges for contemporary pharmaceutical practice due to its long-term nature and dependence on sustained patient engagement. Medication non-adherence remains a major cause of suboptimal therapeutic outcomes and increased health care costs, highlighting the growing importance of pharmaceutical care. This article presents a narrative and conceptual review of the professional responsibility of the pharmacist in chronic pharmacotherapy, focusing on medication adherence as a key ethical and economic dimension of pharmaceutical practice. Professional responsibility is conceptualised as a longitudinal and shared process embedded in routine pharmaceutical care, extending beyond regulatory compliance. The analysis also addresses the impact of digital health technologies on pharmaceutical practice, emphasising the continuing role of professional judgement and accountability. The article affirms the pharmacist’s position as a key professional actor in long-term medication management and health system sustainability.